Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
AL amyloidosis and a critical, early diagnosis
The potential benefits of epigenetic therapy research
Elderly ALL advances: inotuzumab ozogamicin plus mini-hyper-CVD
Benefits of deacetylase inhibitors for leukemia therapy